Memorandum from NZSG
Posted Thursday April 6, 2023
The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website.
Gallery
Related Articles
Welcome to Superstars of IBD 2025!
Tuesday January 14, 2025
On behalf of the New Zealand Society of Gastroenterology and the organising committee of “Superstars of IBD”, we would l...
Congratulations to our NZSG Young Investigator Award (YIA) Winners
Sunday December 15, 2024
At the Annual Scientific Meeting dinner we awarded Young Investigator Awards in several categories.
Get ready for our Membership Platform in 2025
Sunday December 15, 2024
In 2024 the Executive started work on creating a bespoke membership platform which will be launched on March 2025